Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Am Chem Soc ; 145(30): 16899-16905, 2023 08 02.
Article de Anglais | MEDLINE | ID: mdl-37486078

RÉSUMÉ

Chemoproteomic profiling is a powerful approach to define the selectivity of small molecules and endogenous metabolites with the human proteome. In addition to mechanistic studies, proteome specificity profiling also has the potential to identify new scaffolds for biomolecular sensing. Here, we report a chemoproteomics-inspired strategy for selective sensing of acetyl-CoA. First, we use chemoproteomic capture experiments to validate the N-terminal acetyltransferase NAA50 as a protein capable of differentiating acetyl-CoA and CoA. A Nanoluc-NAA50 fusion protein retains this specificity and can be used to generate a bioluminescence resonance energy transfer (BRET) signal in the presence of a CoA-linked fluorophore. This enables the development of a ligand displacement assay in which CoA metabolites are detected via their ability to bind the Nanoluc-NAA50 protein "host" and compete binding of the CoA-linked fluorophore "guest". We demonstrate that the specificity of ligand displacement reflects the molecular recognition of the NAA50 host, while the window of dynamic sensing can be controlled by tuning the binding affinity of the CoA-linked fluorophore guest. Finally, we show that the method's specificity for acetyl-CoA can be harnessed for gain-of-signal optical detection of enzyme activity and quantification of acetyl-CoA from cellular samples. Overall, our studies demonstrate the potential of harnessing insights from chemoproteomics for molecular sensing and provide a foundation for future applications in target engagement and selective metabolite detection.


Sujet(s)
Protéome , Humains , Acétyl coenzyme A/composition chimique , Ligands
2.
ACS Cent Sci ; 7(12): 1963-1965, 2021 Dec 22.
Article de Anglais | MEDLINE | ID: mdl-34963888
3.
J Am Chem Soc ; 138(27): 8324-7, 2016 07 13.
Article de Anglais | MEDLINE | ID: mdl-27331868

RÉSUMÉ

Roseoflavin is a naturally occurring riboflavin analogue with antibiotic properties. It is biosynthesized from riboflavin in a reaction involving replacement of the C8 methyl with a dimethylamino group. Herein we report the identification of a flavin-dependent enzyme that converts flavin mononucleotide (FMN) and glutamate to 8-amino-FMN via the intermediacy of 8-formyl-FMN. A mechanistic proposal for this remarkable transformation is proposed.


Sujet(s)
Riboflavine/analogues et dérivés , Riboflavine/composition chimique , Riboflavine/métabolisme , Flavine mononucléotide/métabolisme , Oxydoréduction , Riboflavine/biosynthèse , Streptomyces/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE